PTC Therapeutics
Utility Patent Applications

Last updated:

List of all PTC Therapeutics patents 60 in total

Status Patent
Application
Utility: METHODS AND COMPOSITIONS FOR TREATMENT OF INFLAMMATION AND OXIDATIVE STRESS External link
Filling date: 8 Sep 2025 Issue date: 18 Aug 2022
Application
Utility: COMPOUNDS FOR TREATING HUNTINGTON'S DISEASE External link
Filling date: 8 Sep 2025 Issue date: 11 Aug 2022
Application
Utility: 2,3,5-TRIMETHYL-6-NONYLCYCLOHEXA-2,5-DIENE-1,4-DIONE FOR SUPPRESSING AND TREATING ALPHA-SYNUCLEINOPATHIES, TAUOPATHIES, AND OTHER DISORDERS External link
Filling date: 8 Sep 2025 Issue date: 14 Jul 2022
Application
Utility: COMPOUNDS FOR TREATING HUNTINGTON'S DISEASE External link
Filling date: 8 Sep 2025 Issue date: 30 Jun 2022
Application
Utility: COMPOUND FORM HAVING ENHANCED BIOAVAILABILITY AND FORMULATIONS THEREOF External link
Filling date: 8 Sep 2025 Issue date: 16 Jun 2022
Application
Utility: DISPERSIBLE TABLET COMPOSITION External link
Filling date: 8 Sep 2025 Issue date: 9 Jun 2022
Application
Utility: METHOD FOR TREATING NONSENSE MUTATION MEDIATED DUCHENNE MUSCULAR DYSTROPHY IN PEDIATRIC PATIENTS External link
Filling date: 8 Sep 2025 Issue date: 9 Jun 2022
Application
Utility: NOVEL RNA TRANSCRIPT External link
Filling date: 8 Sep 2025 Issue date: 26 May 2022
Application
Utility: TABLET FOR USE IN TREATING HUNTINGTON'S DISEASE AND METHOD OF MAKING THE SAME External link
Filling date: 8 Sep 2025 Issue date: 19 May 2022
Application
Utility: COMBINATIONS USEFUL IN A METHOD FOR TREATING SARCOMA External link
Filling date: 8 Sep 2025 Issue date: 19 May 2022
Application
Utility: VECTOR AND METHOD FOR TREATING ANGELMAN SYNDROME External link
Filling date: 8 Sep 2025 Issue date: 19 May 2022
Application
Utility: METHOD FOR TREATING A MULTIPLE MYELOMA External link
Filling date: 8 Sep 2025 Issue date: 12 May 2022
Application
Utility: TREATMENT OF LEIGH SYNDROME AND LEIGH-LIKE SYNDROME WITH TOCOTRIENOL QUINONES External link
Filling date: 8 Sep 2025 Issue date: 5 May 2022
Application
Utility: THIOENO[3,2-B] PYRIDIN-7-AMINE COMPOUNDS FOR TREATING FAMILIAL DYSAUTONOMIA External link
Filling date: 8 Sep 2025 Issue date: 5 May 2022
Application
Utility: PYRROLO[2,3-D]PYRIMIDINE COMPOUNDS FOR TREATING FAMILIAL DYSAUTONOMIA External link
Filling date: 8 Sep 2025 Issue date: 5 May 2022
Application
Utility: 2,3,5-TRIMETHYL-6-NONYLCYCLOHEXA-2,5-DIENE-1,4-DIONE FOR SUPPRESSING AND TREATING ALPHA-SYNUCLEINOPATHIES, TAUOPATHIES, AND OTHER DISORDERS External link
Filling date: 8 Sep 2025 Issue date: 7 Apr 2022
Application
Utility: REDOX-ACTIVE THERAPEUTICS FOR TREATMENT OF MITOCHONDRIAL DISEASES AND OTHER CONDITIONS AND MODULATION OF ENERGY BIOMARKERS External link
Filling date: 8 Sep 2025 Issue date: 24 Feb 2022
Application
Utility: METHODS FOR ENRICHING ALPHA-TOCOTRIENOL FROM MIXED TOCOL COMPOSITIONS External link
Filling date: 8 Sep 2025 Issue date: 17 Feb 2022
Application
Utility: HETEROARYL COMPOUNDS FOR TREATING HUNTINGTON'S DISEASE External link
Filling date: 8 Sep 2025 Issue date: 9 Dec 2021
Application
Utility: METHODS OF ADMINISTERING DEFLAZACORT THERAPY External link
Filling date: 8 Sep 2025 Issue date: 25 Nov 2021
Application
Utility: CRYSTALLINE FORMS OF 3-[5-(2-FLUOROPHENYL)-[1,2,4]OXADIAZOL-3-YL]-BENZOIC ACID FOR THE TREATMENT OF DISEASE External link
Filling date: 8 Sep 2025 Issue date: 28 Oct 2021
Application
Utility: TREATMENT OF OXIDATIVE STRESS DISORDERS INCLUDING CONTRAST NEPHROPATHY, RADIATION DAMAGE AND DISRUPTIONS IN THE FUNCTION OF RED CELLS External link
Filling date: 8 Sep 2025 Issue date: 21 Oct 2021
Application
Utility: HETEROARYL COMPOUNDS FOR TREATING HUNTINGTON'S DISEASE External link
Filling date: 8 Sep 2025 Issue date: 16 Sep 2021
Application
Utility: 2,3,5-TRIMETHYL-6-NONYLCYCLOHEXA-2,5-DIENE-1,4-DIONE FOR SUPPRESSING AND TREATING ALPHA-SYNUCLEINOPATHIES, TAUOPATHIES, AND OTHER DISORDERS External link
Filling date: 8 Sep 2025 Issue date: 9 Sep 2021
Application
Utility: METHODS FOR TREATING HUNTINGTON'S DISEASE External link
Filling date: 8 Sep 2025 Issue date: 9 Sep 2021
Application
Utility: COMPOUNDS FOR TREATING SPINAL MUSCULAR ATROPHY External link
Filling date: 8 Sep 2025 Issue date: 9 Sep 2021
Application
Utility: FLUOROALKYL, FLUOROALKOXY, PHENOXY, HETEROARYLOXY, ALKOXY, AND AMINE 1,4-BENZOQUINONE DERIVATIVES FOR TREATMENT OF OXIDATIVE STRESS DISORDERS External link
Filling date: 8 Sep 2025 Issue date: 5 Aug 2021
Application
Utility: METHOD FOR TREATING PANCREATIC CANCER External link
Filling date: 8 Sep 2025 Issue date: 5 Aug 2021
Application
Utility: HETEROCYCLIC AND HETEROARYL COMPOUNDS FOR TREATING HUNTINGTON'S DISEASE External link
Filling date: 8 Sep 2025 Issue date: 5 Aug 2021
Application
Utility: BIOAVAILABLE ORAL DOSAGE FORMS External link
Filling date: 8 Sep 2025 Issue date: 8 Jul 2021
Application
Utility: 4-(p-QUINONYL)-2-HYDROXYBUTANAMIDE DERIVATIVES FOR TREATMENT OF MITOCHONDRIAL DISEASES External link
Filling date: 8 Sep 2025 Issue date: 17 Jun 2021
Application
Utility: COMPOUNDS FOR TREATING SPINAL MUSCULAR ATROPHY External link
Filling date: 8 Sep 2025 Issue date: 20 May 2021
Application
Utility: TREATMENT OF METHYLMALONIC ACIDURIA, ISOVALERIC ACIDURIA, AND OTHER ORGANIC ACIDURIAS WITH TOCOTRIENOL QUINONES External link
Filling date: 8 Sep 2025 Issue date: 20 May 2021
Application
Utility: TREATMENT OF PERVASIVE DEVELOPMENTAL DISORDERS WITH REDOX-ACTIVE THERAPEUTICS External link
Filling date: 8 Sep 2025 Issue date: 6 May 2021
Application
Utility: METHODS FOR MODULATING RNA SPLICING External link
Filling date: 8 Sep 2025 Issue date: 11 Mar 2021
Application
Utility: 2-SUBSTITUTED AMINO-NAPHTH (1,2-D) IMIDAZOL-5-ONE COMPOUNDS OF PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF External link
Filling date: 8 Sep 2025 Issue date: 4 Mar 2021
Application
Utility: METHODS FOR DOSING AN ORALLY ACTIVE 1,2,4-OXADIAZOLE FOR NONSENSE MUTATION SUPPRESSION THERAPY External link
Filling date: 8 Sep 2025 Issue date: 11 Feb 2021
Application
Utility: COMPOUNDS FOR TREATING HUNTINGTON'S DISEASE External link
Filling date: 8 Sep 2025 Issue date: 28 Jan 2021
Application
Utility: POLYMORPHIC AND AMORPHOUS FORMS OF (R)-2-HYDROXY-2-METHYL-4-(2,4,5-TRIMETHYL-3,6-DIOXOCYCLOHEXA-1,4-DIENYL)B- UTANAMIDE External link
Filling date: 8 Sep 2025 Issue date: 21 Jan 2021
Application
Utility: COMPOUNDS FOR TREATING HUNTINGTON'S DISEASE External link
Filling date: 8 Sep 2025 Issue date: 14 Jan 2021
Application
Utility: METHODS FOR ENRICHING ALPHA-TOCOTRIENOL FROM MIXED TOCOL COMPOSITIONS External link
Filling date: 8 Sep 2025 Issue date: 3 Dec 2020
Application
Utility: METHODS FOR MODIFYING RNA SPLICING External link
Filling date: 8 Sep 2025 Issue date: 26 Nov 2020
Application
Utility: TREATMENT OF LEIGH SYNDROME AND LEIGH-LIKE SYNDROME WITH TOCOTRIENOL QUINONES External link
Filling date: 8 Sep 2025 Issue date: 19 Nov 2020
Application
Utility: CRYSTALLINE FORMS OF 3-[5-(2-FLUOROPHENYL)-[1,2,4]OXADIAZOL-3-YL]-BENZOIC ACID FOR THE TREATMENT OF DISEASE External link
Filling date: 8 Sep 2025 Issue date: 22 Oct 2020
Application
Utility: FLUOROALKYL, FLUOROALKOXY, PHENOXY, HETEROARYLOXY, ALKOXY, AND AMINE 1,4-BENZOQUINONE DERIVATIVES FOR TREATMENT OF OXIDATIVE STRESS DISORDERS External link
Filling date: 8 Sep 2025 Issue date: 22 Oct 2020
Application
Utility: METHOD OF INHIBITING OR REDUCING A CORONAVIRIDAE VIRUS INFECTION External link
Filling date: 8 Sep 2025 Issue date: 8 Oct 2020
Application
Utility: COMPOSITIONS FOR AN ORALLY ACTIVE 1,2,4-OXADIAZOLE FOR THE TREATMENT OF DISEASE External link
Filling date: 8 Sep 2025 Issue date: 20 Aug 2020
Application
Utility: HYDROGEN ISOTOPE-ENRICHED ANALOGUES OF 1,2,4-OXADIAZOLE BENZOIC ACID COMPOUNDS, COMPOSITIONS AND USES THEREOF External link
Filling date: 8 Sep 2025 Issue date: 20 Aug 2020
Application
Utility: DHODH INHIBITOR FOR USE IN TREATING HEMATOLOGIC CANCERS External link
Filling date: 8 Sep 2025 Issue date: 13 Aug 2020
Application
Utility: METHODS FOR TREATING EPILEPSY External link
Filling date: 8 Sep 2025 Issue date: 18 Jun 2020

Showing 1 to 50 of 60 patents.